ICU Medical, Inc. Signs Agreement with ROi for MicroClave® Clear Needlefree IV Connector
SAN CLEMENTE, Cali, June 26, 2012 /PRNewswire/ — ICU Medical, Inc. (NASDAQ: ICUI) today announced that it has signed a contract with ROi (Resource Optimization & Innovation) for MicroClave® Clear neutral displacement needlefree IV connectors to be used on central and peripheral IV lines at Mercy, the eighth largest Catholic health care system in the United States, serving more than 3 million people annually. ROi is the health care supply chain company founded by Mercy more than a decade ago.
The MicroClave Clear is the only neutral displacement connector that combines market-leading Clave® technology–the best selling needlefree IV connector technology in the world–with a clear housing that lets clinicians visualize the fluid path so they can clearly see whether they have completely flushed the connector after blood draws or administration. The neutral displacement straight fluid path design, split-septum and minimal deadspace of the MicroClave Clear work together to help minimize blood reflux into the tip of the catheter upon connection or disconnection of the luer. In addition, in a study of the bacteria transfer and biofilm formation properties of needlefree connectors, the MicroClave proved to provide an effective barrier to bacterial transfer and colonization, outperforming all connectors tested in terms of bacteria transfer, biofilm formation, and biofilm bacteria formation.(1)
“We are proud that ROi awarded us the contract to provide our market-leading needlefree IV connector technology to the clinicians and patients at Mercy,” explained Mark Jorgensen, ICU Medical’s General Manager for National Accounts. “ROi’s focus on supply chain excellence and Mercy’s long-standing and unwavering commitment to providing quality patient care are well known. We are excited to be in their company.”
(1)( )Ryder M, James G, Pulchini E, Bickle L, Parker A. Differences in bacterial transfer and fluid path colonization through needlefree connector-catheter systems in vitro. Presented at the Infusion Nursing Society Meeting, May 2011.
Contact: Tom McCall
Vice President, Marketing
About ICU Medical, Inc.: ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical’s products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company’s complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needle-free I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit www.icumed.com.
SOURCE ICU Medical, Inc.